Showing results (181-190 of 1,225) with videos related to
Sort By:
Pageof 123
Multiple Sclerosis and Related Disorders|September 21, 2016
CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis - Targeting T or B cells?Marie Colombe Agahozo, Laura Peferoen, David Baker, et al.Iucrj|May 18, 2017
Applications of contact predictions to structural biologyFelix Simkovic, Sergey Ovchinnikov, David Baker, et al.Proteins|November 16, 2007
Ranking predicted protein structures with support vector regressionJian Qiu, Will Sheffler, David Baker, et al.Plos One|June 30, 2016
Characterisation of Transcriptional Changes in the Spinal Cord of the Progressive Experimental Autoimmune Encephalomyelitis Biozzi ABH Mouse Model by RNA SequencingIoanna Sevastou, Gareth Pryce, David Baker, et al.Trends in Cancer|January 9, 2019
TGF-β Family Signaling Pathways in Cellular DormancyChloé Prunier, David Baker, Peter Ten Dijke, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 27, 2025
Mechanistic biology linking traumatic brain injury to multiple sclerosis susceptibilityDavid Baker, Lars Alfredsson, Anna Karin Hedström, et al.Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|June 9, 2012
Pseudotumor of hemophilia in the mandible of a patient with hemophilia ARoger R Throndson, David Baker, Patrick Kennedy, et al.Clinical Toxicology (Philadelphia, Pa.)|February 3, 2026
Gabapentin exposures in those aged 50 years and older reported to United States poison centers: reasons for exposure and medical outcomesNamkee G Choi, C Nathan Marti, S David BakerThe Journal of Obstetrics and Gynaecology Research|January 3, 2013
Endometrial cancer in a 14-year-old girl with Cowden syndrome: a case reportWilliam David Baker, Andrew Patrick Soisson, Mark Kane DodsonThe Lancet. Neurology|July 10, 2003
The therapeutic potential of cannabisDavid Baker, Gareth Pryce, Gavin Giovannoni, et al.Pageof 123